Literature DB >> 2895579

Incidence and geographic distribution of serologically verified cases of nephropathia epidemica in Sweden.

B Settergren1, P Juto, G Wadell, B Trollfors, S R Norrby.   

Abstract

A nationwide survey of hospitalized, serologically verified adult nephropathia epidemica cases in Sweden from 1978 to 1981 was performed. Serum was collected from 1,063 patients with a diagnosis of nephropathia epidemica or one of 10 other renal diseases with related symptoms. Sera were analyzed by indirect immunofluorescence technique for the presence of immunoglobulin G antibodies to Hantaan virus, causative agent of Korean hemorrhagic fever that cross-reacts with the nephropathia epidemica agent. Antibodies were present in 368 patients, 355 of whom also fulfilled four or more of six criteria for clinical diagnosis of nephropathia epidemica. The male:female ratio was 2.7:1. The total number of cases in Sweden varied between 26 and 144 per year, which coincided with the fluctuations in small rodent populations. The highest incidence was found in Västerbotten County, with a maximum crude incidence rate of 23.5 cases per 100,000 inhabitants per year. Mean crude incidence in Sweden during the study period was 1.3 cases per 100,000 inhabitants per year. The southernmost cases lived in proximity to the 59th parallel. Thus, nephropathia epidemica was found to be prevalent south of the 60th parallel, which was previously assumed to be its southern boundary.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2895579     DOI: 10.1093/oxfordjournals.aje.a114862

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

1.  [Acute myopia and progressive acute renal failure in a 28-year old active horsewoman].

Authors:  C Rüster; J Gerth; U Ott; R Pfeifer; G Wolf
Journal:  Internist (Berl)       Date:  2006-08       Impact factor: 0.743

2.  Seroprevalence of hantavirus antibodies in Germany as determined by a new recombinant enzyme immunoassay.

Authors:  L Zöller; M Faulde; H Meisel; B Ruh; P Kimmig; U Schelling; M Zeier; P Kulzer; C Becker; M Roggendorf
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

3.  Clinical quiz. Nephropathia epidemica. Specific IgM antibodies against Puumalavirus can be found in serum.

Authors:  E Esbjörner; C Ahlm
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

4.  Prevalence of serum IgG antibodies to Puumala virus (haemorrhagic fever with renal syndrome) in northern Sweden.

Authors:  C Ahlm; M Linderholm; P Juto; B Stegmayr; B Settergren
Journal:  Epidemiol Infect       Date:  1994-08       Impact factor: 2.451

5.  Cytokine expression during early and late phase of acute Puumala hantavirus infection.

Authors:  Mahmoud Sadeghi; Isabella Eckerle; Volker Daniel; Ulrich Burkhardt; Gerhard Opelz; Paul Schnitzler
Journal:  BMC Immunol       Date:  2011-11-16       Impact factor: 3.615

6.  Human hantavirus infections, Sweden.

Authors:  Gert E Olsson; Fredrik Dalerum; Birger Hörnfeldt; Fredrik Elgh; Thomas R Palo; Per Juto; Clas Ahlm
Journal:  Emerg Infect Dis       Date:  2003-11       Impact factor: 6.883

7.  Predicting high risk for human hantavirus infections, Sweden.

Authors:  Gert E Olsson; Marika Hjertqvist; Ake Lundkvist; Birger Hörnfeldt
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

8.  [Emerging zoonoses: Hantavirus infections].

Authors:  E Krautkrämer; M Zeier
Journal:  Nephrologe       Date:  2007-11-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.